Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· February 25, 2026

Navitas outlines $3.5B high-power market opportunity and projects sequential growth through 2026

View original at seekingalpha.com
Navitas outlines $3.5B high-power market opportunity and projects sequential growth through 2026 Earnings Call Insights: Navitas Semiconductor Corporation (NVTS) Q4 2025 MANAGEMENT VIEW * CEO Chris Allexandre described Q4 as a productive quarter, highlighting the company's accelerated transformation to "Navitas 2.0" an…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 800-volt architecture collaboration continuing but too early to confirm timing

    80% confidence
  • Margin expansion expected from combination of end product mix and optimized process, yields and packaging costs

    80% confidence
  • Q4 2025 revenue exceeded high end of guidance at $7.3 million compared to $10.1 million in Q3 2025, reflecting strategic decision to deprioritize low-power China mobile and consumer business

    80% confidence
  • Q4 was a productive quarter highlighting accelerated transformation to Navitas 2.0 and realignment toward high-power markets

    80% confidence
  • Q4 revenue came at high end of guidance at $7.3 million, with high-power markets representing majority of total revenue for the first time

    80% confidence
  • Distribution channel partners reduced from about 40 to less than 10

    80% confidence
  • Architecture change driven by U.S. hyperscalers, with OEM and ODM engagement in Taiwan, China, and U.S.

    80% confidence
  • Q1 2026 gross margin expected to be 38.7%, plus or minus 25 basis points

    80% confidence
  • Navitas has both SiC and GaN solutions for 800-volt rail, welcomes use of either on primary side based on need

    80% confidence
  • Q4 was the bottom for Navitas revenue

    80% confidence
  • Partnership with Infineon continues with cross-license, but companies don't compete in all sockets targeted

    80% confidence
  • Navitas does not leverage or benefit from Infineon partnership in competitive situations

    80% confidence
  • High-power markets represented majority of quarterly revenue for first time in company history, with mobile declining to less than 25%

    80% confidence
  • Q4 GAAP results included $16.6 million restructuring and impairment charge associated with realigning organization and distribution channel to focus on high-power markets

    80% confidence
  • Anticipate return to top line sequential growth starting in Q1 2026, fueled by increased revenue from high-power markets

    80% confidence
  • Four high-growth market segments collectively represent a serviceable addressable market of $3.5 billion by 2030, split roughly evenly between GaN and high-voltage SiC, with combined CAGR of more than 60%

    80% confidence
  • Q1 2026 revenue expected to increase sequentially to between $8 million and $8.5 million

    80% confidence
  • Q1 2026 operating expenses anticipated to remain approximately $15 million

    80% confidence
  • All high-power markets expected to perform on go-forward basis as mobile becomes immaterial

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Navitas outlines $3.5B high-power market opportunity and projects sequential growth through 2026 — Source | Via News | Via News